Guide to buying AbbVie stock in Canada

AbbVie is a drug manufacturers - general business based in the US. AbbVie stocks (ABBV) are listed on the NYSE, and all prices are listed in US Dollars.

At its last market close, AbbVie stock price was $294.83, which is an increase of 1.39% over the previous week. AbbVie employs 57,000 staff and has a trailing 12-month revenue of around $66 billion.

Keep reading to see up-to-date AbbVie stock price and performance data, along with a step-by-step guide for how to buy AbbVie stock in Canada.

AbbVie (ABBV) stock summary

Company stock name	AbbVie Inc
Stock ticker symbol	ABBV
Exchange	NYSE
Open	$293.95
High	$295.40
Low	$283.32
Close	$294.83
Adjusted closing	$294.83
Volume The number of stocks traded during the day	8,404,865
52-week stock price range	$188.25 – $298.74
Where to buy AbbVie stock	Buy on Questrade

The values in this table are accurate as of the market close on November 3, 2026, and all amounts are in USD.

Can I buy AbbVie stock in Canada?

Yes, you can buy AbbVie stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NYSE exchange. Platforms like Questrade and Wealthsimple will allow you to directly buy AbbVie stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy AbbVie stock

AbbVie stock chart (NYSE: ABBV)

This chart tracks AbbVie stock price performance over time.

AbbVie stock price

AbbVie's stock price at the last available market close was $294.83 (as of November 3, 2026). For comparison, seven days ago AbbVie's stock price was $285.64. A full 30 days ago it was $262.82, and a year ago it was $215.89.

Is AbbVie stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for AbbVie stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy AbbVie stock on the TSX?

No, you cannot buy AbbVie stock on the TSX because AbbVie stock is not listed on the TSX. Instead, AbbVie stock is listed on the NYSE under the symbol "ABBV."

That said, if you're wondering how to invest in AbbVie stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Questrade or Wealthsimple.

Dive deeper: Our picks for the best stocks to buy right now in Canada

AbbVie stock dividends

AbbVie dividend payout ratio: 54% of net profits

Indicated dividend yield: 2.4%

Recently AbbVie has paid out, on average, around 54% of net profits as dividends.

Analysts estimate a "forward annual dividend yield" of 2.4% of the current stock value. This means that, over a year, based on recent payouts (which are not a guarantee of future payouts), AbbVie shareholders could enjoy a 2.4% return on their shares in the form of dividend payments.

Over the last 12 months, AbbVie has paid about $6.92 per share in dividends.

AbbVie's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

AbbVie's next dividend payout is expected around February 16, 2027. To benefit, you'll need to buy before January 15, 2027.

AbbVie stock performance metrics

Here are some common key metrics for AbbVie stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• AbbVie's P/E ratio

  AbbVie's current share price divided by its per-share earnings (EPS) over the past 12 months gives a trailing price/earnings (P/E) ratio of roughly 49x.

  That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

• AbbVie's PEG ratio

  AbbVie's price/earnings-to-growth (PEG) ratio comes out to about 0.5883.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in AbbVie's expected earnings growth.

• AbbVie's EBITDA

  AbbVie's EBITDA (earnings before interest, taxes, depreciation and amortization) is $31.7 billion.

How volatile is AbbVie stock?

Over the last 12 months, AbbVie's stocks price has ranged from $188.25 to as high as $298.74. AbbVie's beta measurement of stock volatility is 0.19. For comparison, the market (NYSE) average beta is 1. This would suggest that AbbVie's stocks are less volatile than average (on this exchange).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of AbbVie's beta stock volatility rating.

AbbVie Inc company and revenue performance

Market Capitalization The total market value of AbbVie's outstanding shares	$510.4 billion
Gross profit (TTM)	$48.7 billion
Operating margin (TTM)	39.53%
Profit margin	15.67%
Revenue (TTM)	$66 billion
Return on assets (TTM)	10.51%
Return on equity (TTM)	62.25%
Earnings per share (TTM)	$5.82
50-day moving stock price average The average share price over the last 50 days	$269.29
200-day moving stock price average The average share price over the last 200 days	$237.10

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on November 3, 2026.

AbbVie company profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer.

It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis.

Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

• Common company-related questions about AbbVie

  What percentage of AbbVie is owned by insiders or institutions?
  Currently 0.11% of AbbVie stocks are held by insiders and 77.387% by institutions.

  How many people work for AbbVie?
  Latest data suggests 57,000 work at AbbVie.

  When does the fiscal year end for AbbVie?
  AbbVie's fiscal year ends in December.

  Where is AbbVie based?
  AbbVie's address is: 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400

Compare trading platforms to buy AbbVie stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from AbbVie stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling AbbVie stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about AbbVie stock

• Can I buy AbbVie stock directly as a Canadian investor?

  Yes, Canadian investors can buy AbbVie stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying AbbVie stock in our table here.

• How much is AbbVie stock worth?

  As of the last market close (on November 3, 2026), AbbVie stock is worth $294.83 per share.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of AbbVie stock?

  Yes, it may be possible to buy fractional shares of AbbVie stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in AbbVie stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  4 of 4 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted 9.6 Excellent Questrade	9.6 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA, Margin	$0	$0	Get $50 cash back when you open a Questrade self-directed investing account through Finder. T&Cs apply.	Go to site View details Compare product selection Compare	loading
  8.6 Great Wealthsimple Investing	8.6 Great	Stocks, Options, ETFs, Cryptocurrency	RRSP, RESP, RRIF, TFSA, Personal, FHSA, Margin	$0	$0	Get a 1% match cash bonus on eligible $25,000+ transfers from other financial institutions to your Wealthsimple Self-directed Investing and Managed Investing accounts. T&Cs apply.	Go to site View details Compare product selection Compare	loading
  9.4 Excellent Interactive Brokers	9.4 Excellent	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint, Business, FHSA, Margin	Min $1.00, Max 0.5%	$0	Continue View details Compare product selection Compare	loading
  8.6 Great Moomoo	8.6 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, Margin	$1.49/stock	$0	Continue View details Compare product selection Compare	loading

  loading

  Load More

  Showing 4 of 4 results

  Compare other products

  Looking for other options? Check out these similar products.

  How we picked these

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.